Reduction-responsive sulfur dioxide polymer prodrug nanoparticles loaded with irinotecan for combination osteosarcoma therapy.

Nanotechnology
Yongshuang LiZhiyu Zhang

Abstract

Combination therapy can boost the therapeutic effectiveness of monotherapies by achieving synergy between therapeutic agents. Herein, a reduction-responsive sulfur dioxide (SO2) polymer prodrug was synthesized as a nanocarrier to load irinotecan (IRN) to be used in combination osteosarcoma therapy. The SO2 prodrug (denoted as mPEG-PLG (DNs)) was synthesized by coupling a small-molecule SO2 donor, N-(3-azidopropyl)-2,4-dinitrobenzenesulfonamide (AP-DNs), to the side chains of methoxy poly (ethylene glycol)-block-poly (γ-propargyl-L-glutamate) block copolymer. The mPEG-PLG (DNs) had the ability to self-assemble into micelles while simultaneously encapsulating IRN in aqueous media. The formed micelles led to enhanced SO2 and IRN release in reductive conditions. Using nile red as a model drug, the loaded micelles were efficiently internalized by cancer cells, demonstrated by confocal laser scanning microscopy and flow cytometry. The release of SO2 within nanoparticles (NPs) in tumor cells led to enhanced intracellular reactive oxygen species amounts together with induced oxidative destruction to cancer cells. Furthermore, the IRN-loaded SO2 polymer prodrug NPs mediated synergistic therapeutic effects against osteosarcoma cells, lea...Continue Reading

References

Feb 13, 2001·Trends in Neurosciences·D E BarañanoS H Snyder
Apr 1, 1956·Archives of Biochemistry and Biophysics·T P SINGER, E B KEARNEY
Nov 5, 1960·JAMA : the Journal of the American Medical Association·M C LIH GRABSTALD
Apr 2, 2005·Nature Reviews. Cancer·Michael DeanSusan Bates
Jul 24, 2007·Biomaterials·Ranieri CanceddaMaddalena Mastrogiacomo
Oct 25, 2007·Biochemical Society Transactions·L Li, P K Moore
Jul 24, 2008·British Journal of Cancer·T LammersG Storm
Feb 13, 2009·Biomaterials·Johannes C ReichertDietmar W Hutmacher
Feb 25, 2009·Reviews on Environmental Health·Hong ChenPaul J Villeneuve
Nov 17, 2010·Journal of the American Chemical Society·Sang-Min LeeSonBinh T Nguyen
Feb 8, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ru ChengZhiyuan Zhong
Mar 15, 2011·Cancer Chemotherapy and Pharmacology·Davide StaedlerLucienne Juillerat-Jeanneret
Jul 4, 2012·Nature Reviews. Clinical Oncology·Charles S CleelandJamey Skillings
Jun 8, 2013·Nature Medicine·Jean-Pierre Levesque, Ingrid G Winkler
Nov 26, 2013·Advanced Drug Delivery Reviews·Nicolas BertrandOmid C Farokhzad
Dec 20, 2013·Science Translational Medicine·Edward Kai-Hua Chow, Dean Ho
Jan 15, 2014·Life Sciences·Xin-Bao WangHong Cui
Jun 26, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M WilhelmUNKNOWN ENCCA (European Network for Cancer research in Children and Adolescents)
Oct 9, 2014·Angewandte Chemie·Tianmeng SunYounan Xia
Apr 12, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ankita GupteCarl R Walkley
Aug 26, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael S IsakoffRichard Gorlick
Sep 9, 2015·Nature Biotechnology·Elvin BlancoMauro Ferrari
Feb 4, 2016·Oxidative Medicine and Cellular Longevity·Yaqian HuangHongfang Jin
Feb 25, 2017·Advanced Materials·Qihang SunYouqing Shen
Jan 16, 2019·ACS Nano·Shihua LiHuanghao Yang
Sep 21, 2019·ACS Nano·Lichan ChenJibin Song
Apr 22, 2020·Chemical Communications : Chem Comm·Yu ZhangChunsheng Xiao

❮ Previous
Next ❯

Citations

Sep 21, 2021·Antioxidants & Redox Signaling·Yaqian HuangHongfang Jin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.